Table 2 Pulmonary function among Ecuadorian patients with CF divided in three age groups
Age group | Follow-up | *FEV1%pred. (SD) | *FVC %pred. (SD) | FEV1/FVC (SD) |
|---|---|---|---|---|
5 to 9 years (n = 11) | At diagnosis | 105.3 (13.1) | 106,3 (15.9) | 98,5 (8.2) |
3-month | 95,8 (27.2) | 100,8 (22.3) | 92,5 (10.9) | |
6-month | 104,7 (30.7) | 109,4 (25.3) | 93,7 (11.9) | |
9-month | 105,3 (29.5) | 107,0 (23.5) | 95,3 (10.9) | |
10 to 14 years (n = 15) | At diagnosis | 87,7 (12.8) | 97,5 (11.5) | 87,9 (4.3) |
3-month | 87,1 (20.9) | 97,0 (18.5) | 88,0 (6.6) | |
6-month | 86,6 (22.7) | 94,1 (20.1) | 88,0 (8.3) | |
9-month | 80,4 (18.3) | 92,3 (16.3) | 81,7 (11.9) | |
≥ 15 years (n = 8) | At diagnosis | 90,4 (19.9) | 99,6 (18.3) | 87,6 (8.0) |
3-month | 85,8 (22.3) | 100,0 (18.2) | 83,0 (11.6) | |
6-month | 76,9 (31.9) | 90,1 (25.3) | 72,8 (29.4) | |
9-month | 79,3 (25.8) | 91,3 (17.2) | 83,8 (15.1) |